• In late June 2026, Applied Materials introduced a suite of new epitaxy, CMP, deposition and eBeam systems aimed at enabling advanced 3D chip architectures, DRAM performance gains and high-yield advanced packaging for AI workloads, while index provider FTSE Russell simultaneously reclassified the stock, removing it from several value benchmarks and adding it to the Russell Top 50 Index.
• The product launch underscores Applied Materials’ central role in tooling for high-bandwidth memory and advanced packaging at a time when major chipmakers are committing very large, multi‑year investment plans to expand AI-oriented manufacturing capacity.
• We’ll now examine how this new AI-focused equipment portfolio, especially for high-bandwidth memory and advanced packaging, could reshape Applied Materials’ investment narrative.

Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

Applied Materials Investment Narrative Recap

To own Applied Materials today, you have to believe AI-related chip spending will keep supporting high demand for its tools, especially in memory and advanced packaging, while accepting that equipment orders can swing sharply with sentiment. The short term catalyst remains execution on AI capacity builds at key customers; the recent Russell index reclassification and AI tool launch do not change that. The biggest near term risk is that elevated expectations meet a pause or pullback in wafer fab equipment spending.

The June 2026 launch of new epitaxy, CMP, deposition and eBeam systems for DRAM and high bandwidth memory packaging looks particularly important, because it directly targets bottlenecks in AI memory bandwidth and 3D stacking yields. If customers adopt these tools at scale, it could support Applied’s role in AI focused manufacturing, but it also raises the stakes if memory makers or advanced packaging investments slow faster than the market currently assumes.

But against the optimism, investors should also be aware of how quickly sentiment can turn if AI equipment orders slow or export rules tighten...

Applied Materials’ narrative projects $49.4 billion revenue and $16.5 billion earnings by 2029.

Uncover how Applied Materials' forecasts yield a $511.17 fair value, a 21% downside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts are far more cautious than the consensus, assuming revenue reaches about US$44.2 billion and earnings US$12.4 billion by 2029, and warning that trade restrictions and slower DRAM and ICAPS demand could justify a much lower future valuation multiple. Their view predates the latest AI tool launches and index move, so you may want to compare how that more pessimistic path fits with today’s headlines.

Explore 10 other fair value estimates on Applied Materials - why the stock might be worth less than half the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Applied Materials research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Applied Materials research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Applied Materials' overall financial health at a glance.

No Opportunity In Applied Materials?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Find 41 companies with promising cash flow potential yet trading below their fair value.
• Capitalize on the AI infrastructure supercycle with our selection of the 53 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.